首页> 外国专利> Ophthalmic compsn. for treating ageing of the lens - contains glutamic acid, cysteine, glycine and fructose-1,6-di:phosphate

Ophthalmic compsn. for treating ageing of the lens - contains glutamic acid, cysteine, glycine and fructose-1,6-di:phosphate

机译:眼科药物用于治疗镜片老化-包含谷氨酸,半胱氨酸,甘氨酸和果糖1,6-二:磷酸盐

摘要

Opthalmic compsn. contains as active ingredients (A) a mixt. of the 3 amino acids which make up glutathione (Glu, Cys, Gly) and (B) D-fructose-1,6-diphosphate (I), opt. used as their inorganic or organic salts. Pref. the amino acids are present in the same mole ratio, 1:1:1, as in glutathione and the compsn. is esp. an aq. soln. contg. 0.01-5 (pref. 1-4) w/v% amino acids and 0.1-10 (pref. 5-10) w/v% (I), or their salts, Esp. (I) is used as its Na salt. Used esp. for treating ageing of the lens in human and veterinary medicine. The compsn. maintains the normal metabolic function of the lens, esp. a normal ATP level. There are no side effects or toxicity.
机译:眼科医师包含混合料作为有效成分(A)。构成谷胱甘肽的3个氨基酸(Glu,Cys,Gly)和(B)D-果糖-1,6-二磷酸(I)中的一种,优化。用作其无机或有机盐。首选氨基酸以与谷胱甘肽和复合物相同的摩尔比(1:1:1:1)存在。特别是。一个水soln。续0.01-5(优选1-4)w / v%氨基酸和0.1-10(优选5-10)w / v%(I)或它们的盐(I)用作其钠盐。二手的在人类和兽医学中用于治疗晶状体的老化。该compsn。保持晶状体的正常代谢功能,尤其是。正常的ATP水平。没有副作用或毒性。

著录项

  • 公开/公告号FR2425858B1

    专利类型

  • 公开/公告日1980-10-31

    原文格式PDF

  • 申请/专利权人 CHAUVIN BLACHE LABORATOIRES;

    申请/专利号FR19780014854

  • 发明设计人

    申请日1978-05-19

  • 分类号A61K31/70;A61K31/195;

  • 国家 FR

  • 入库时间 2022-08-22 17:22:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号